Home » Topics » Regulatory » Patents

Patents
RSS

SKB reveals selective inhibitors of bacterial enzyme

Dec. 5, 1997

DuPont Merck develops novel CRF antagonists

Dec. 5, 1997

Vitronectin receptor antagonists described by Hoechst

Dec. 4, 1997

Bayer develops CETP inhibitors

Dec. 4, 1997

Diagnostic use of specific sigma2 ligands described by Wake Forest University

Dec. 4, 1997

MDR modulators prepared at Janssen

Dec. 4, 1997

Antiviral thiazolidines and thiazolidinones from INSERM

Dec. 4, 1997

Neurogen patents new dopamine receptor subtype-specific ligands

Dec. 3, 1997

VEGF receptor tyrosine kinase inhibitors under development at Zeneca

Dec. 3, 1997

Compounds for 5-HT-mediated disorders from Astra

Dec. 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...